Clinical Trial Update: Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial exploring intranasal levodopa for Parkinson's Disease has completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Intranasal Levodopa (levodopa)

Snippet

Sponsor: Impel Pharmaceuticals | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-08-12